The Tolerability & Palatability of UC-II® for Feline Patients

Orthopedics|Sponsored

Sign in to Print/View PDF

The Tolerability & Palatability of UC-II® for Feline Patients

Sponsored by Vetoquinol

More than 90% of feline veterinary patients have radiographic joint changes.1 Careful monitoring indicates that despite a lack of obvious lameness, it is possible to detect signs of discomfort and response to therapy in feline patients with joint issues.2,3 

90% of cats have radiographic signs of joint changes.

90% of cats have radiographic signs of joint changes.

During the study, each cat was offered a joint supplement containing UC-II® (Flexadin Advanced®) for 40 days, and consumption was monitored over 15 minutes.

Seventy percent of the 33 cats took the supplement voluntarily, generally within the first 5 minutes. Patients tolerated the supplement well; no remarkable changes were noted on physical examination and no changes in bodyweight were observed.4

UC-II® Proposed Mechanism

70% of cats consumed within 5 minutes.

  • Inflammation reduced through oral tolerance.
  • Similar mechanism to that used to prevent immune response to food proteins.

UC-II® reduces inflammation by inducing immune tolerance to help break the cycle of discomfort and inflammation. It has been studied in humans, horses, and dogs as a potential therapy for addressing joint issues.5-9

The present study shows Flexadin® Advanced is a safe, palatable joint supplement option for cats.

References

Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Practice Tools

Topic

Orthopedics

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2018 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 05/08/2018) Terms of Use (Updated 05/08/2018)